BR9914042A - Derivados da aminoalquil-3,4-diidroquinolina como inibidores da sintase de monóxido de nitrogênio - Google Patents

Derivados da aminoalquil-3,4-diidroquinolina como inibidores da sintase de monóxido de nitrogênio

Info

Publication number
BR9914042A
BR9914042A BR9914042-0A BR9914042A BR9914042A BR 9914042 A BR9914042 A BR 9914042A BR 9914042 A BR9914042 A BR 9914042A BR 9914042 A BR9914042 A BR 9914042A
Authority
BR
Brazil
Prior art keywords
aminoalkyl
inhibitors
nitrogen monoxide
dihydroquinoline derivatives
monoxide synthase
Prior art date
Application number
BR9914042-0A
Other languages
English (en)
Inventor
Stefan Jaroch
Hartmut Rehwinkel
Peter Hoelscher
Detlev Suelzle
Margrit Hillmann
Gerardine Anne Burton
Fiona Mcdougall Mcdonald
Original Assignee
Schering Aktiengellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengellschaft filed Critical Schering Aktiengellschaft
Publication of BR9914042A publication Critical patent/BR9914042A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings

Abstract

Patente de Invenção: <B>"DERIVADOS DA AMINOALQUIL-3,4-DIIDROQUINOLINA COMO INIBIDORES DA SINTASE DE MONóXIDO DE NITROGêNIO"<D>. Descrevem-se compostos de fórmula I, suas formas tautoméricas e isoméricas e seus sais, bem como o processo para sua produção e a sua utilização em medicamentos.
BR9914042-0A 1998-09-24 1999-09-20 Derivados da aminoalquil-3,4-diidroquinolina como inibidores da sintase de monóxido de nitrogênio BR9914042A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19845830A DE19845830A1 (de) 1998-09-24 1998-09-24 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln
PCT/EP1999/007091 WO2000017167A1 (de) 1998-09-24 1999-09-20 Aminoalkyl-3,4-dihydrochinolin-derivate als no synthase inhibitoren

Publications (1)

Publication Number Publication Date
BR9914042A true BR9914042A (pt) 2001-06-19

Family

ID=7883472

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914042-0A BR9914042A (pt) 1998-09-24 1999-09-20 Derivados da aminoalquil-3,4-diidroquinolina como inibidores da sintase de monóxido de nitrogênio

Country Status (22)

Country Link
US (1) US7067667B2 (pt)
EP (1) EP1115708B1 (pt)
JP (1) JP2002526478A (pt)
KR (1) KR20010075326A (pt)
CN (1) CN1137097C (pt)
AR (1) AR021824A1 (pt)
AT (1) ATE264308T1 (pt)
AU (1) AU752412B2 (pt)
BR (1) BR9914042A (pt)
CA (1) CA2340990A1 (pt)
DE (2) DE19845830A1 (pt)
DK (1) DK1115708T3 (pt)
ES (1) ES2219067T3 (pt)
HU (1) HUP0104151A3 (pt)
NO (1) NO20011506L (pt)
NZ (1) NZ510561A (pt)
PE (1) PE20001073A1 (pt)
PL (1) PL346838A1 (pt)
PT (1) PT1115708E (pt)
SK (1) SK3732001A3 (pt)
TW (1) TW565556B (pt)
WO (1) WO2000017167A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ510875A (en) 1998-11-13 2003-10-31 Schering Ag Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors in medicaments for treating neurodegenerative diseases
FR2865827A1 (fr) * 2004-01-29 2005-08-05 St Microelectronics Sa Securisation du mode de test d'un circuit integre

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN153442B (pt) * 1981-12-22 1984-07-14 Hoechst Pharmaceuticals Limite
DE3305329A1 (de) * 1983-02-17 1984-08-23 Hoechst Ag, 6230 Frankfurt Polyzyklische bisamidine, verfahren zu ihrer herstellung und ihre verwendung als chemotherapeutika
US5629322A (en) * 1994-11-15 1997-05-13 Merck & Co., Inc. Cyclic amidine analogs as inhibitors of nitric oxide synthase
WO1997009982A1 (fr) * 1995-09-14 1997-03-20 Nippon Kayaku Kabushiki Kaisha Inhibiteur de monoxyde d'azote synthetase qui contient des 2-aminopyridines en tant qu'ingredient actif
DE19538088A1 (de) * 1995-10-13 1997-04-17 Bernd Prof Dr Clement Phenanthridinderivate und ihre Herstellung
PT891332E (pt) * 1996-03-29 2004-07-30 Pfizer Derivados de 6-fenilpiridil-2-amina
DE19806348A1 (de) * 1998-02-12 1999-08-19 Schering Ag 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln

Also Published As

Publication number Publication date
HUP0104151A2 (hu) 2002-03-28
KR20010075326A (ko) 2001-08-09
PL346838A1 (en) 2002-02-25
PE20001073A1 (es) 2000-10-18
WO2000017167A1 (de) 2000-03-30
US7067667B2 (en) 2006-06-27
US20040127712A1 (en) 2004-07-01
EP1115708A1 (de) 2001-07-18
NZ510561A (en) 2003-11-28
DK1115708T3 (da) 2004-08-02
CA2340990A1 (en) 2000-03-30
JP2002526478A (ja) 2002-08-20
CN1319093A (zh) 2001-10-24
NO20011506D0 (no) 2001-03-23
ES2219067T3 (es) 2004-11-16
AU752412B2 (en) 2002-09-19
HUP0104151A3 (en) 2002-06-28
DE59909194D1 (en) 2004-05-19
DE19845830A1 (de) 2000-03-30
SK3732001A3 (en) 2001-12-03
PT1115708E (pt) 2004-08-31
AU6195599A (en) 2000-04-10
ATE264308T1 (de) 2004-04-15
NO20011506L (no) 2001-05-23
CN1137097C (zh) 2004-02-04
AR021824A1 (es) 2002-08-07
EP1115708B1 (de) 2004-04-14
TW565556B (en) 2003-12-11

Similar Documents

Publication Publication Date Title
CY1108010T1 (el) Παραγωγα ξανθινης, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
PT1076657E (pt) Novos hidroxi-indoles, sua utilizacao como inibidores da fosfodiesterase 4 e processo para a sua producao
BR0308967A (pt) Derivados de quinolina e isoquinolina, um processo para a sua preparação e sua aplicação como inibidores de inflamação
BR0112786A (pt) Inibidores de inflamação não-esteroidais
CY1110749T1 (el) Νεα παραγωγα ξανθινης, παραγωγη αυτων και χρηση τους ως φαρμακων
BRPI0408347A (pt) derivados de pirimidina
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
CY1106890T1 (el) Παραγωγα της ακριδινης και η χρηση τους ως φαρμακων
BR9916111A (pt) Derivados de fenilglicina
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
NO980313L (no) N-(aroyl)glysin-hydroksaminsyre-derivater og beslektete forbindelser
BR0005636A (pt) Método para a produção de 4-carboxiamino-1,2,3,4-tetrahidroquinolina 2-substituìda
TR200002605T2 (tr) Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri
BR0100982A (pt) Processo para a preparação de derivados deresorcinol
BR0110357A (pt) Sais bicìclicos e n-aciclados de aminas imidazo - 3 e imidazo -5
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
BR0109542A (pt) Derivados de imidazopirina alquilados
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
ATE210647T1 (de) Kondensierte piperin-derivate als stickstoffmonoxid-synthese-hemmer
BR9914042A (pt) Derivados da aminoalquil-3,4-diidroquinolina como inibidores da sintase de monóxido de nitrogênio
BR0308195A (pt) Derivados de isoquinolina
BR0013751A (pt) Processo para produção de derivados de ácido naftiridina-3-carboxìlico
ATE348800T1 (de) 4&#39;-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
BR0214578A (pt) Compostos azopolicìclicos fundidos com arila

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1942 DE 25/03/2008.